Skip Navigation


Rheumatology Advance Access originally published online on May 4, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/6/687    most recent
keh206v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chira, P.
Right arrow Articles by Sandborg, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chira, P.
Right arrow Articles by Sandborg, C.
Related Collections
Right arrow Juvenile Idiopathic Arthritis
Right arrow Health Economics
Right arrow Education
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 6 © British Society for Rheumatology 2004; all rights reserved


EDITORIAL

Adolescent rheumatology transitional care: steps to bringing health policy into practice

P. Chira and C. Sandborg

Division of Pediatric Rheumatology PTD, Stanford University Medical Center, Stanford, California, USA.

Correspondence to: C. Sandborg. E-mail: sandborg@stanford.edu

The first 150 words of the full text of this article appear below.

Transitional care for adolescents with childhood-onset chronic diseases, including juvenile idiopathic arthritis (JIA), has become of topical interest, especially as more children with disabling or chronic conditions are surviving into adulthood. This issue has transcended into the realm of health policy, leading to the formation of national initiatives to address transitional care for adolescents and young adults with special health-care needs (ASHCN) in the United States (US) and the United Kingdom (UK). In this issue of Rheumatology, Shaw and colleagues, on behalf of the British Paediatric Rheumatology Group (BRPG), continue to report findings on their comprehensive analysis of the state of transitional care in the UK for adolescents with JIA. This study reflects how we are clearly only at the initial steps of addressing some of the objectives listed in these health-care policies.

The term transition has been defined by the Society of Adolescent Medicine as ‘the purposeful, planned . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
L. R. Wedderburn, P. Woo, and R. G. Hull
Paediatric rheumatology: a bright future in the UK and Europe
Rheumatology, April 1, 2005; 44(4): 423 - 425.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. G. Dubey, C. Roberts, and A. O. Adebajo
Rheumatology training in the UK: the trainees' perspective - issues surrounding paediatric rheumatology
Rheumatology, February 1, 2005; 44(2): 264 - 264.
[Full Text] [PDF]